Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Type of content
Search
123 result(s) found, displaying 51 to 75
-
-
Safety alertsMedicines Safety Update - Information for consumers
-
Safety alertsSafety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation
-
Safety alertsTGA investigation - potential low levels of contamination with N-nitrosovarenicline
-
Safety alertsSafety investigation in response to concerns that increased antidepressant prescribing had resulted in an increased rate of suicide in young people in Australia
-
Market actionsHealth professionals and consumers are advised that GE Healthcare, in consultation with the TGA, has initiated a recall for product correction for a number of its nuclear medicine imaging systems.
-
Safety alertsPoly Implant Prothèse (PIP) update
-
Safety alertsSafety advisory - contamination of rifampicin medicines with low levels of nitrosamine impurity.
-
Safety alertsSafety advisory - alternative product filling shortage may cause airway constriction if administered via inhalation
-
-
Safety alerts
-
Safety alertsSafety advisory - alternative product filling shortage may cause airway irritation if administered via inhalation
-
Market actionsRecall for product correction - child-resistant caps may not function correctly
-
Market actionsHazard alert - potential for valve to move after implantation.
-
-
-
Market actionsHazard alert - risks of leaks, stent movement and aneurysm enlargement
-
Market actionsRecall for product correction - potential for audible alarms not sounding
-
Market actionsRecall for product correction - fire risk from faulty component
-
-
-
-
Safety alertsPIP breast implants are known to have been used in Australia from September 1999 until April 2010, when non-implanted PIP breast implants were recalled from the market following advice from the French regulator (AFSSAPS) that in making these devices the manufacturer had used unapproved materials which may affect their safety and performance.
-
Market actionsPIP breast implants: Consumer questions & answers
-
Market actionsCertain batches of Clexane (enoxaparin) have been recalled because of an impurity. Stop using it, check with your healthcare provider, and return any affected product. If you have concerns, consult your doctor.